Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT01253902 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: bimatoprost ophthalmic solution 0.01%
DRUG: travoprost ophthalmic solution 0.004%
DRUG: latanoprost ophthalmic solution 0.005%

Sponsor

Allergan